54 related articles for article (PubMed ID: 30725414)
1. High Efficacy of Recombinant Methioninase on Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Cancer.
Hoffman RM; Murakami T; Kawaguchi K; Igarashi K; Tan Y; Li S; Han Q
Methods Mol Biol; 2019; 1866():149-161. PubMed ID: 30725414
[TBL] [Abstract][Full Text] [Related]
2. Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.
Kawaguchi K; Miyake K; Han Q; Li S; Tan Y; Igarashi K; Lwin TM; Higuchi T; Kiyuna T; Miyake M; Oshiro H; Bouvet M; Unno M; Hoffman RM
Cell Cycle; 2018; 17(7):868-873. PubMed ID: 29623758
[TBL] [Abstract][Full Text] [Related]
3. Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models.
Kawaguchi K; Igarashi K; Li S; Han Q; Tan Y; Miyake K; Kiyuna T; Miyake M; Murakami T; Chmielowski B; Nelson SD; Russell TA; Dry SM; Li Y; Unno M; Eilber FC; Hoffman RM
Oncotarget; 2018 Jan; 9(1):915-923. PubMed ID: 29416666
[TBL] [Abstract][Full Text] [Related]
4. Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet.
Sato M; Han Q; Mizuta K; Mori R; Kang BM; Morinaga S; Kobayashi N; Ichikawa Y; Nakajima A; Hoffman RM
In Vivo; 2024; 38(3):1459-1464. PubMed ID: 38688589
[TBL] [Abstract][Full Text] [Related]
5. Recombinant-methioninase-producing
Kubota Y; Han Q; Morinaga S; Mizuta K; Bouvet M; Tsunoda T; Hoffman RM
Cancer Diagn Progn; 2023; 3(6):649-654. PubMed ID: 37927811
[TBL] [Abstract][Full Text] [Related]
6. Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model.
Sato M; Mizuta K; Han Q; Morinaga S; Kang BM; Kubota Y; Mori R; Baranov A; Kobayashi K; Ardjmand D; Kobayashi N; Bouvet M; Ichikawa Y; Nakajima A; Hoffman RM
In Vivo; 2024; 38(3):1058-1063. PubMed ID: 38688611
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Methioninase Decreased the Effective Dose of Irinotecan by 15-fold Against Colon Cancer Cells: A Strategy for Effective Low-toxicity Treatment of Colon Cancer.
Sato M; Han Q; Kubota Y; Baranov A; Ardjmand D; Mizuta K; Morinaga S; Kang BM; Kobayashi N; Bouvet M; Ichikawa Y; Nakajima A; Hoffman RM
Anticancer Res; 2024 Jan; 44(1):31-35. PubMed ID: 38159986
[TBL] [Abstract][Full Text] [Related]
8. The Combination of Methioninase and Ethionine Exploits Methionine Addiction to Selectively Eradicate Osteosarcoma Cells and Not Normal Cells and Synergistically Down-regulates the Expression of
Aoki Y; Kubota Y; Han Q; Masaki N; Obara K; Bouvet M; Chawla SP; Tome Y; Nishida K; Hoffman RM
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):679-685. PubMed ID: 38035708
[TBL] [Abstract][Full Text] [Related]
9. High-fat diet promotes tumor growth in the patient-derived orthotopic xenograft (PDOX) mouse model of ER positive endometrial cancer.
Shen K; Shen D; Jin D; Zheng Y; Zhu Y; Zhao X; Zhang Z; Wang N; Chen H; Yang L
Sci Rep; 2023 Oct; 13(1):16537. PubMed ID: 37783734
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived orthotopic xenograft (PDOX) mouse model of adult rhabdomyosarcoma invades and recurs after resection in contrast to the subcutaneous ectopic model.
Igarashi K; Kawaguchi K; Kiyuna T; Murakami T; Miwa S; Nelson SD; Dry SM; Li Y; Singh A; Kimura H; Hayashi K; Yamamoto N; Tsuchiya H; Eilber FC; Hoffman RM
Cell Cycle; 2017 Jan; 16(1):91-94. PubMed ID: 27830986
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide combined with irinotecan regresses a cisplatinum-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) precision-oncology mouse model.
Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Miyake M; Li Y; Nelson SD; Dry SM; Singh AS; Elliott IA; Russell TA; Eckardt MA; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM
Oncotarget; 2018 Jan; 9(8):7774-7781. PubMed ID: 29487690
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Recombinant Methioninase on Late-stage Patient Cancer in the Histoculture Drug Response Assay (HDRA) as a Potential Functional Biomarker of Sensitivity to Methionine-restriction Therapy in the Clinic.
Kubota Y; Sasaki M; Han Q; Hozumi C; Tsunoda T; Hoffman RM
Cancer Diagn Progn; 2024; 4(3):239-243. PubMed ID: 38707720
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Methioninase Lowers the Effective Dose of Regorafenib Against Colon-Cancer Cells: A Strategy for Widespread Clinical Use of a Toxic Drug.
Choobin BB; Kubota Y; Han Q; Ardjmand D; Morinaga S; Mizuta K; Bouvet M; Tsunoda T; Hoffman RM
Cancer Diagn Progn; 2023; 3(6):655-659. PubMed ID: 37927805
[TBL] [Abstract][Full Text] [Related]
14. Targeting Methionine Addiction of Cancer Cells with Methioninase.
Pokrovsky VS; Qoura LA; Demidova EA; Han Q; Hoffman RM
Biochemistry (Mosc); 2023 Jul; 88(7):944-952. PubMed ID: 37751865
[TBL] [Abstract][Full Text] [Related]
15. A review on L-methioninase in cancer therapy: Precision targeting, advancements and diverse applications for a promising future.
Javia BM; Gadhvi MS; Vyas SJ; Ghelani A; Wirajana N; Dudhagara DR
Int J Biol Macromol; 2024 Apr; 265(Pt 2):130997. PubMed ID: 38508568
[TBL] [Abstract][Full Text] [Related]
16. Patient-Derived Orthotopic Xenograft Models for High-Grade Pediatric Brain Cancers.
Buck J; Hii H; Endersby R
Methods Mol Biol; 2024; 2806():41-53. PubMed ID: 38676795
[TBL] [Abstract][Full Text] [Related]
17. One-Carbon and Polyamine Metabolism as Cancer Therapy Targets.
Islam A; Shaukat Z; Hussain R; Gregory SL
Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551330
[TBL] [Abstract][Full Text] [Related]
18. Over-methylation of Histone H3 Lysines Is a Common Molecular Change Among the Three Major Types of Soft-tissue Sarcoma in Patient-derived Xenograft (PDX) Mouse Models.
Aoki Y; Yamamoto J; Tome Y; Hamada K; Masaki N; Inubushi S; Tashiro Y; Bouvet M; Endo I; Nishida K; Hoffman RM
Cancer Genomics Proteomics; 2021; 18(6):715-721. PubMed ID: 34697064
[TBL] [Abstract][Full Text] [Related]
19. Current Approaches for Personalized Therapy of Soft Tissue Sarcomas.
Kirsanov KI; Lesovaya EA; Fetisov TI; Bokhyan BY; Belitsky GA; Yakubovskaya MG
Sarcoma; 2020; 2020():6716742. PubMed ID: 32317857
[TBL] [Abstract][Full Text] [Related]
20. Methionine Dependence of Cancer.
Kaiser P
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32276408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
